Humoral Response of Different Types of SARS-CoV-2 Vaccines in Patients with Autoimmune Rheumatic Diseases: Experiences from a Serbian Cohort
CONCLUSIONS: In ARDs patients, the highest level of serum IgG antibody against S1/S2 proteins was achieved with the mRNA vaccine, irrespective of the therapy applied or the type of the disease. We recommend a booster dose with mRNA vaccine in all ARDs for the highest SARS-CoV-2 protection without serious post-vaccinal reactions observed.PMID:37698308
Source: The Israel Medical Association Journal - Category: General Medicine Authors: Ljudmila Stojanovich Natasa Stanisavljevic Aleksandra Djokovic Milomir Milanovic Jovica Saponjski Yehuda Shoenfeld Source Type: research
More News: Autoimmune Disease | Coronavirus | Covid Vaccine | COVID-19 | General Medicine | Israel Health | Middle East Health | Respiratory Medicine | Rheumatology | SARS | Serbia Health | Statistics | Vaccines